May 9, 2019 - James Dabney and his team were recognized in "Law360's Weekly Verdict: Legal Lions & Lambs."
A single sentence in a patent settlement prevents Amgen Inc. from halting sales of a generic version of its blockbuster calcium-control drug Sensipar, a Delaware federal judge ruled in an opinion released Friday, handing a win to attorneys at Hughes Hubbard & Reed LLP and Farnan LLP who represented generic drugmaker Cipla Ltd. Cipla is represented by Sue L. Robinson, Brian E. Farnan and Michael J. Farnan of Farnan LLP, and James W. Dabney, Patrice P. Jean, Dina Hoffer, Deanne K. Cevasco, David E. Lansky and Lynn M. Russo of Hughes Hubbard & Reed LLP.
Click here to view full article.